Calumet Specialty Products Partners (NASDAQ:CLMT) Given Buy Rating at HC Wainwright
Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report)'s stock had its "buy" rating restated by equities researchers at HC Wainwright in a research report issued to clients and investors on Monday,Benzinga reports. They currently have a $25.00 target price on the oil and gas company's stock. HC Wainwright's target price would indicate a potential upside of 12.61% from the company's current price.
A number of other brokerages have also weighed in on CLMT. Wells Fargo & Company boosted their price objective on shares of Calumet Specialty Products Partners from $25.00 to $29.00 and gave the stock an "overweight" rating in a report on Monday, October 21st. StockNews.com assumed coverage on shares of Calumet Specialty Products Partners in a research note on Wednesday, October 23rd. They issued a "sell" rating for the company. TD Cowen raised their price objective on Calumet Specialty Products Partners from $22.00 to $27.00 and gave the company a "buy" rating in a research note on Thursday, October 17th. Finally, The Goldman Sachs Group decreased their price objective on Calumet Specialty Products Partners from $17.00 to $15.00 and set a "buy" rating on the stock in a report on Monday, August 5th. One analyst has rated the stock with a sell rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, Calumet Specialty Products Partners presently has an average rating of "Moderate Buy" and an average price target of $23.75.
View Our Latest Research Report on Calumet Specialty Products Partners
Shares of NASDAQ:CLMT opened at $22.20 on Monday. The firm has a fifty day moving average of $19.26 and a 200 day moving average of $16.96. Calumet Specialty Products Partners has a 52-week low of $9.97 and a 52-week high of $25.29. The firm has a market capitalization of $1.91 billion, a PE ratio of -8.04 and a beta of 1.90.
Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last posted its quarterly earnings data on Friday, November 8th. The oil and gas company reported ($1.18) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.59) by ($0.59). The firm had revenue of $1.10 billion during the quarter, compared to analysts' expectations of $888.36 million. The company's quarterly revenue was down 4.3% on a year-over-year basis. During the same period in the prior year, the firm earned $0.03 EPS. On average, sell-side analysts forecast that Calumet Specialty Products Partners will post -2.17 EPS for the current fiscal year.
Large investors have recently added to or reduced their stakes in the company. Sapient Capital LLC raised its stake in shares of Calumet Specialty Products Partners by 9.5% during the second quarter. Sapient Capital LLC now owns 11,501 shares of the oil and gas company's stock valued at $185,000 after acquiring an additional 1,000 shares during the last quarter. FAS Wealth Partners Inc. raised its position in Calumet Specialty Products Partners by 4.5% during the 2nd quarter. FAS Wealth Partners Inc. now owns 54,126 shares of the oil and gas company's stock valued at $869,000 after purchasing an additional 2,308 shares during the last quarter. Founders Financial Alliance LLC lifted its holdings in Calumet Specialty Products Partners by 8.4% in the 2nd quarter. Founders Financial Alliance LLC now owns 48,400 shares of the oil and gas company's stock worth $777,000 after buying an additional 3,750 shares during the period. ARS Investment Partners LLC lifted its holdings in Calumet Specialty Products Partners by 16.7% in the 2nd quarter. ARS Investment Partners LLC now owns 31,500 shares of the oil and gas company's stock worth $506,000 after buying an additional 4,500 shares during the period. Finally, Wedbush Securities Inc. bought a new stake in shares of Calumet Specialty Products Partners in the 2nd quarter worth approximately $169,000. Institutional investors own 34.41% of the company's stock.
Calumet, Inc manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to various consumer-facing and industrial markets in North America and internationally. It operates through Specialty Products and Solutions; Montana/Renewables; and Performance brands segments.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Calumet Specialty Products Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet Specialty Products Partners wasn't on the list.
While Calumet Specialty Products Partners currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Alphabet (GOOGL) is in the midst of a year-end rally, climbing 10% since September, and some analysts predict it could gain another 30% by Christmas!
Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools.
CLMTAd (Ad)(Ad)